Healthcare -
Biotechnology - NASDAQ - US
$ 2.12
10.4 %
$ 147 M
Market Cap
-0.68
P/E
IKT - COMMON STOCK
Common Stock IKT - Inhibikase Therapeutics, Inc.
6.19 K
LAST VALUE
-50.41%
2 YEAR CAGR
-5.44%
5 YEAR CAGR
0.00%
10 YEAR CAGR